Yıl: 2020 Cilt: 29 Sayı: 3 Sayfa Aralığı: 221 - 225 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2020.4143 İndeks Tarihi: 15-06-2021

Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease

Öz:
Objective: Chronic kidney disease (CKD) and diabetes mellitus (DM) both have an increased risk of cardiovascular disease (CVD). Based on estimated glomerular filtration rate values, both CVD and CKD have powerful and independent relationships even after adjusting for known CVD risk factors, history of CVD events, and proteinuria. However, there are limited data about the individual effects of the underlying etiology of CKD on CVD. This study aims to evaluate the cardiovascular status (CVS) of patients with diabetic and non-diabetic stage 3, 4, and 5 CKD with non-invasive methods.Materials and Methods: A total of 187 patients who had stage 3-5 CKD were grouped on the basis of whether they had DM or not. The non-invasive cardiovascular markers such as pulse wave velocity, carotid intima media thickness, central systolic and diastolic pressures, and central pulse pressures were evaluated in these patients.Results: A total of 187 patients with CKD were recruited for this study. Of them, 46 (25%) had diabetic CKD (mean age, 57.7±9.2 years) and 141 (75%) had non-diabetic CKD (mean age, 56.8±12.4 years). Clinical systolic blood pressure, clinical pulse pressure, central systolic blood pressure, central pulse pressure, cardiac output, and pulse wave velocity were significantly higher in patients with CKD who had DM.Conclusion: The impaired renal function and DM have additive effects on the development of peripheral arterial calcification. The CVS of patients with CKD and DM is worse than that of patients with CKD who were not diabetic; therefore, extra effort must be given for diabetic CKD patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. KDIGO. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013; 3: 1-150.
  • 2. Boddana P, Caskey F, Casula A, Ansell D. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK renal registry and international comparisons. Nephron Clin Pract 2009; 111: c269-76. [Crossref]
  • 3. McKinlay J, Marceau L. US public health and the 21st century: Diabetes mellitus. Lancet 200; 356: 757-61. [Crossref]
  • 4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305. [Crossref]
  • 5. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008; 156: 277-83. [Crossref]
  • 6. Bazyluk A, Malyszko J, Zbroch E. Cardiovascular risk in chronic kidney disease: What is new in the pathogenesis and treatment? Postgrad Med 2018; 130: 461-9. [Crossref]
  • 7. Choi IJ, Lim S, Choo EH, Kim JJ, Hwang BH, Kim TH, et al. Differential impact of chronic kidney disease on coronary calcification and atherosclerosis in asymptomatic individuals with or without diabetes: Analysis from a coronary computed tomographic angiography registry. Cardiorenal Med 2018; 8: 228-36. [Crossref]
  • 8. Patel T, Charytan DM. Cardiovascular complications in diabetic kidney disease. Semin Dial 2010; 23: 169-77. [Crossref]
  • 9. Kim JJ, Hwang BH, Choi IJ, Choo EH, Lim S, Kim JK. Impact of diabetes duration on the extent and severity of coronary atheroma burden and long-term clinical outcome in asymptomatic type 2 diabetic patients: Evaluation by coronary CT angiography. Eur Heart J Cardiovasc Imaging 2015; 16: 1065-73. [Crossref]
  • 10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-70. [Crossref]
  • 11. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098. [Crossref]
  • 12. Weiss W, Gohlisch C, Harsch-Gladisch C, Tölle M, Zidek W, van der Giet M. Oscillometric estimation of central blood pressure: Validation of the Mobil-OGraph in comparison with the SphygmoCor device. Blood Press Monit 2012; 17: 128-31. [Crossref]
  • 13. Afsar B, Elsurer R. The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients. J Am Soc Hypertens 2014; 8: 28-35. [Crossref]
  • 14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-536. [Crossref]
  • 15. Johnson JG, Gore SM, Firth J. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: A systematic quantitative overview of the literature. Nephrol Dial Transplant 1999; 14: 2156-64. [Crossref]
  • 16. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001; 12: 2117- 24.
  • 17. Choi IJ, Lim S, Choo E-H, Kim J-J, Hwang B-H, Kim T-H, et. al. Differential impact of chronic kidney disease on coronary calcification and atherosclerosis in asymptomatic ndividuals with or without diabetes: Analysis from a Coronary Computed Tomographic Angiography Registry. Cardiorenal Med 2018; 8: 228-36 [Crossref]
  • 18. McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: Current evidence and clinical importance. Eur Heart J 2014; 35: 1719-25. [Crossref]
  • 19. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735-8. [Crossref]
  • 20. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 2009; 54: 1730-4. [Crossref]
  • 21. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: A critical review of their strengths and weaknesses. J Hypertens 2003; 21: 463-72 [Crossref]
  • 22. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Lamm G, et al. Increased arterial wave reflections predict severe cardiovascular eventsbin patients undergoing percutaneous coronary interventions. Eur Heart J 2005; 26: 2657-63. [Crossref]
  • 23. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-analysis. Eur Heart J 2010; 31: 1865-71. [Crossref]
  • 24. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation 2006; 113: 657-63. [Crossref]
  • 25. Tąpolska M, Spałek M, Szybowicz U, Domin R, Owsik K, Sochacka K, et al. Arterial stiffness parameters correlate with estimated cardiovascular risk in humans: A clinical study. Int J Environ Res Public Health 2019; 16: 2547. [Crossref]
  • 26. Matsuda N, Takei T, Fujiu A, Ogawa T, Nitta K. Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb 2009; 16: 57-62. [Crossref]
  • 27. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Circulation 1995; 91: 1432-43. [Crossref]
APA KARAKÖSE S, GÜNEY I (2020). Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. , 221 - 225. 10.5152/turkjnephrol.2020.4143
Chicago KARAKÖSE SÜLEYMAN,GÜNEY IBRAHIM Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. (2020): 221 - 225. 10.5152/turkjnephrol.2020.4143
MLA KARAKÖSE SÜLEYMAN,GÜNEY IBRAHIM Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. , 2020, ss.221 - 225. 10.5152/turkjnephrol.2020.4143
AMA KARAKÖSE S,GÜNEY I Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. . 2020; 221 - 225. 10.5152/turkjnephrol.2020.4143
Vancouver KARAKÖSE S,GÜNEY I Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. . 2020; 221 - 225. 10.5152/turkjnephrol.2020.4143
IEEE KARAKÖSE S,GÜNEY I "Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease." , ss.221 - 225, 2020. 10.5152/turkjnephrol.2020.4143
ISNAD KARAKÖSE, SÜLEYMAN - GÜNEY, IBRAHIM. "Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease". (2020), 221-225. https://doi.org/10.5152/turkjnephrol.2020.4143
APA KARAKÖSE S, GÜNEY I (2020). Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. Turkish journal of nephrology (Online), 29(3), 221 - 225. 10.5152/turkjnephrol.2020.4143
Chicago KARAKÖSE SÜLEYMAN,GÜNEY IBRAHIM Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. Turkish journal of nephrology (Online) 29, no.3 (2020): 221 - 225. 10.5152/turkjnephrol.2020.4143
MLA KARAKÖSE SÜLEYMAN,GÜNEY IBRAHIM Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. Turkish journal of nephrology (Online), vol.29, no.3, 2020, ss.221 - 225. 10.5152/turkjnephrol.2020.4143
AMA KARAKÖSE S,GÜNEY I Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. Turkish journal of nephrology (Online). 2020; 29(3): 221 - 225. 10.5152/turkjnephrol.2020.4143
Vancouver KARAKÖSE S,GÜNEY I Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease. Turkish journal of nephrology (Online). 2020; 29(3): 221 - 225. 10.5152/turkjnephrol.2020.4143
IEEE KARAKÖSE S,GÜNEY I "Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease." Turkish journal of nephrology (Online), 29, ss.221 - 225, 2020. 10.5152/turkjnephrol.2020.4143
ISNAD KARAKÖSE, SÜLEYMAN - GÜNEY, IBRAHIM. "Evaluation of Cardiovascular Status with Non-InvasiveMarkers in Patients with Diabetic and Non-DiabeticChronic Kidney Disease". Turkish journal of nephrology (Online) 29/3 (2020), 221-225. https://doi.org/10.5152/turkjnephrol.2020.4143